Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -36.68x is 89% below its 5-year average of -19.44x, around the middle of its 5-year range (-72.00x–-0.03x).
As of the fiscal period ended Tuesday, March 31, 2026. 32.50% above its 12-month average of -54.34x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): -36.68x.
INTEREST COVERAGE RATIO
-36.68x
INTEREST COVERAGE RATIO AVG TTM
-54.34x
INTEREST COVERAGE RATIO AVG 3Y
-54.34x
INTEREST COVERAGE RATIO AVG 5Y
-19.44x
INTEREST COVERAGE RATIO AVG 10Y
-3.03x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+32.50%
CURRENT VS 3Y AVG
+32.50%
CURRENT VS 5Y AVG
-88.71%
CURRENT VS 10Y AVG
-1111.38%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-469.58%
vs the sector median at left
Novocure Ltd
Market Cap
$1.74B
Interest Coverage Ratio
-36.68x
TTM Avg
-54.34x
3Y Avg
-54.34x
5Y Avg
-19.44x
Market Cap
$1.74B
Interest Coverage Ratio
-596.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.74B
Interest Coverage Ratio
0.86x
TTM Avg
0.86x
3Y Avg
0.86x
5Y Avg
0.86x
Market Cap
$1.74B
Interest Coverage Ratio
0.93x
TTM Avg
0.93x
3Y Avg
0.93x
5Y Avg
0.93x
Market Cap
$1.75B
Interest Coverage Ratio
1.43x
TTM Avg
1.58x
3Y Avg
1.58x
5Y Avg
1.43x
Market Cap
$1.73B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.77B
Interest Coverage Ratio
-206.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.71B
Interest Coverage Ratio
-429.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.71B
Interest Coverage Ratio
2.86x
TTM Avg
2.86x
3Y Avg
2.86x
5Y Avg
6.42x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novocure Ltd (NVCR) | $1.74B | -36.68x | -54.34x | -54.34x | -19.44x |
| Absci Corporation (ABSI)vs › | $1.74B | -596.74x | N/A | N/A | N/A |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.74B | 0.86x | 0.86x | 0.86x | 0.86x |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 0.93x | 0.93x | 0.93x | 0.93x |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 1.43x | 1.58x | 1.58x | 1.43x |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | N/A | N/A | N/A | N/A |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | -206.92x | N/A | N/A | N/A |
| Personalis, Inc. (PSNL)vs › | $1.71B | -429.55x | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 2.86x | 2.86x | 2.86x | 6.42x |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.70B | -28.85x | N/A | N/A | N/A |
Interest Coverage
-36.7x
Debt/Equity
0.69
Current Ratio
2.89
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -36.68x |
| 2025-12-31 | -72.00x |
| 2022-06-30 | -9.48x |
| 2022-03-31 | -0.47x |
| 2021-09-30 | -4.32x |
| 2021-06-30 | -13.08x |
| 2021-03-31 | -0.03x |
| 2020-12-31 | 2.04x |
| 2020-09-30 | 3.77x |
| 2020-06-30 | 2.55x |
| 2020-03-31 | -1.39x |
| 2019-12-31 | 0.12x |
| 2019-09-30 | 1.51x |
| 2019-06-30 | 0.97x |
| 2019-03-31 | -2.58x |
| 2018-12-31 | -4.92x |
| 2018-09-30 | -2.19x |
| 2018-06-30 | -2.48x |
| 2018-03-31 | -2.61x |
| 2017-12-31 | -1.54x |
| 2017-09-30 | -2.75x |
| 2017-06-30 | -7.11x |
| 2017-03-31 | -5.47x |
| 2016-12-31 | -7.27x |
| 2016-09-30 | -12.91x |
| 2016-06-30 | -67.09x |
| 2016-03-31 | -58.17x |
| 2015-12-31 | -59.08x |
| 2015-09-30 | -29.96x |
| 2015-06-30 | -31.06x |
| 2015-03-31 | -37.13x |
| 2014-09-30 | -337.83x |
